Nautilus Biotechnology, Inc. (NAUT) vs Prelude Therapeutics Incorporated (PRLD)
- Nautilus Biotechnology, Inc. NAUT 2.06 −4.63%
- Prelude Therapeutics Incorporated PRLD 3.26 −1.81%
Nautilus Biotechnology, Inc. and Prelude Therapeutics Incorporated are both Biotechnology companies. Nautilus Biotechnology, Inc. and Prelude Therapeutics Incorporated are of similar size ($274.9M and $265.0M). Nautilus Biotechnology, Inc. has the higher net margin (0.00% vs −269.8%) and the lower return on invested capital (−83.3% vs 0.00%). Across the 13 metrics below, Nautilus Biotechnology, Inc. leads on 8 and Prelude Therapeutics Incorporated on 5.
Valuation
Profitability
| Metric | NAUT | PRLD | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (300.56%) | 0.00% |
| Net margin | 0.00% | (269.75%) | 0.00% |
| Free cash flow margin | 0.00% | (148.30%) | 0.00% |
| Return on equity | (36.21%) | (57.73%) | (56.36%) |
| Return on assets | (30.00%) | (39.76%) | (48.04%) |
| Return on invested capital | (83.32%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack